HHS should protect payments to clinical trial participants
Summary
The U.S. Department of Health and Human Services (HHS) Office of Inspector General is asking for public input on protecting payments made to people who take part in clinical trials. Research supports paying participants, including those who use drugs, because it helps create better medical treatments.Key Facts
- The HHS Office of Inspector General is considering rules about payments to clinical trial participants.
- They want the public to share their opinions on this topic.
- Paying people for participating in trials is important for medical research.
- This includes participants who currently use drugs.
- Compensation encourages participation and helps gather useful data.
- The goal is to support the development of effective treatments.
- Protecting these payments may ensure fair treatment of trial participants.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
